| 000 | 01809 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516060049.0 | ||
| 264 | 0 | _c20111213 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1465-3621 | ||
| 024 | 7 |
_a10.1093/jjco/hyr140 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yao-Chung | |
| 245 | 0 | 0 |
_aSunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma. _h[electronic resource] |
| 260 |
_bJapanese journal of clinical oncology _cNov 2011 |
||
| 300 |
_a1277-81 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aChromosomes, Human, X _xgenetics |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Fusion |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChang, Peter Mu-Hsin | |
| 700 | 1 | _aLiu, Chun-Yu | |
| 700 | 1 | _aYang, Chih-Yu | |
| 700 | 1 | _aChen, Ming-Han | |
| 700 | 1 | _aPan, Chin-Chen | |
| 700 | 1 | _aChen, Ming-Huang | |
| 773 | 0 |
_tJapanese journal of clinical oncology _gvol. 41 _gno. 11 _gp. 1277-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jjco/hyr140 _zAvailable from publisher's website |
| 999 |
_c21201554 _d21201554 |
||